Can blood pressure be lowered safely in older adults with lacunar stroke? the secondary prevention of small subcortical strokes study experience

Journal of the American Geriatrics Society

Volumn 63, Issue 4, 2015, Pages 722-729

  White, Carole L ^a   Szychowski, Jeff M ^b   Pergola, Pablo E ^a,c   Field, Thalia S ^d   Talbert, Robert ^e   Lau, Helena ^f   Peri, Kalyani ^b   Benavente, Oscar R ^d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Renal Associates PA   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^f BOSTON MEDICAL CENTER   (United States)

Author keywords

blood pressure management; hypertension; ischemic stroke; lacunar stroke; stroke prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BLURRED VISION; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DIZZINESS; FAINTNESS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; HYPERTENSION; LACUNAR STROKE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RECURRENT DISEASE; SECONDARY PREVENTION; SMOKING; STANDING; SYSTOLIC BLOOD PRESSURE; UNSTEADINESS; WHITE MATTER INJURY; AGE; BLOOD PRESSURE; COMPLICATION; DRUG EFFECTS; STROKE;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; STROKE; STROKE, LACUNAR;

EID: 84928424111     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13349     Document Type: Article

References (25)

1. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041.
2. Gueyffier F, Boissel JP, Boutitie F, et al. Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators. Stroke 1997; 28: 2557-2562.
3. Law MR, Morris JK, Wald NJ,. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
4. Rashid P, Leonardi-Bee J, Bath P,. Blood pressure reduction and secondary prevention of stroke and other vascular events: A systematic review. Stroke 2003; 34: 2741-2748.
5. Rothwell PM, Algra A, Amarenco P,. Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet 2011; 377: 1681-1692.
6. Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke 2006; 37: 1583-1633.
7. Borzecki AM, Glickman ME, Kader B, et al. The effect of age on hypertension control and management. Am J Hypertens 2006; 19: 520-527.
8. Egan BM, Zhao Y, Axon RN,. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303: 2043-2050.
9. Lloyd-Jones DM, Evans JC, Levy D,. Hypertension in adults across the age spectrum: Current outcomes and control in the community. JAMA 2005; 294: 466-472.
10. Brescacin L,. Is it possible to apply secondary stroke prevention guidelines to very old populations? Cardiovasc Hematol Disord Drug Targets 2011; 11: 9-16.
11. Sanossian N, Ovbiagele B,. Prevention and management of stroke in very elderly patients. Lancet Neurol 2009; 8: 1031-1041.
12. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008; 31: 2115-2127.
13. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898.
14. Ogihara T, Saruta T, Rakugi H, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension Study. Hypertension 2010; 56: 196-202.
15. Zhang Y, Zhang X, Liu L, et al. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. Eur Heart J 2011; 32: 1500-1508.
16. Benavente OR, White CL, Pearce L, et al. The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke 2011; 6: 164-175.
17. The SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: The SPS3 randomised trial. Lancet 2013; 382: 507-515.
18. The SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med 2012; 367: 817-825.
19. White CL, Szychowski JM, Roldan A, et al. Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis 2013; 22: 764-774.
20. Alamowitch S, Eliasziw M, Algra A, et al. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet 2001; 357: 1154-1160.
21. Beckett N, Peters R, Tuomilehto J, et al. Immediate and late benefits of treating very elderly people with hypertension: Results from active treatment extension to hypertension in the very elderly randomised controlled trial. BMJ 2012; 344: d7541.
22. Pergola PE, White CL, Szychowski JM, et al. Achieved blood pressures in the Secondary Prevention of Small Subcortical Strokes (SPS3) study: Challenges and lessons learned. Am J Hypertens 2014; 27: 1052-1060.
23. James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507-520.
24. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-1357.
25. Bejot Y, Rouaud O, Jacquin A, et al. Stroke in the very old: Incidence, risk factors, clinical features, outcomes and access to resources-a 22-year population-based study. Cerebrovasc Dis 2010; 29: 111-121.